L

LSL Pharma Group Inc
XTSX:LSL

Watchlist Manager
LSL Pharma Group Inc
XTSX:LSL
Watchlist
Price: 0.435 CAD
Market Cap: CA$55.1m

Income Statement

Earnings Waterfall
LSL Pharma Group Inc

Income Statement
LSL Pharma Group Inc

Rotate your device to view
Income Statement
Currency: CAD
Jul-2011 Oct-2011 Jan-2012 Apr-2012 Jul-2012 Oct-2012 Jan-2013 Apr-2013 Mar-2022 Jun-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
2
2
2
2
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
2
N/A
3
+76%
3
+5%
4
+18%
7
+62%
10
+53%
12
+21%
14
+18%
16
+10%
18
+12%
20
+14%
23
+15%
27
+15%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
(3)
(4)
(3)
(3)
(5)
(8)
(10)
(11)
(12)
(12)
(14)
(16)
(19)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(1)
N/A
(1)
-51%
0
N/A
1
+1 700%
2
+43%
2
+6%
2
+46%
3
+35%
4
+22%
5
+35%
6
+18%
7
+8%
8
+17%
Operating Income
Operating Expenses
(0)
(0)
(0)
(0)
(2)
(2)
(2)
(2)
(1)
(3)
(2)
(2)
(3)
(4)
(4)
(4)
(4)
(5)
(0)
(1)
(6)
Selling, General & Administrative
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(3)
(3)
(4)
(4)
(4)
(4)
(5)
(5)
(6)
Research & Development
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Operating Expenses
0
0
0
(0)
(2)
(1)
(1)
(1)
0
0
0
0
0
0
0
0
0
0
5
5
0
Operating Income
(0)
N/A
(0)
-56%
(0)
-186%
(0)
-3%
(2)
-359%
(2)
+2%
(2)
+10%
(2)
+2%
(2)
-14%
(4)
-89%
(2)
+45%
(1)
+52%
(1)
-36%
(2)
-58%
(2)
+20%
(1)
+62%
(0)
+68%
1
N/A
6
+623%
6
+1%
2
-74%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
(0)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
1
(2)
(2)
(2)
(3)
0
(0)
(0)
5
0
0
4
Total Other Income
0
0
0
0
0
0
0
0
0
(0)
(1)
(3)
(3)
(2)
(1)
0
0
(1)
(1)
(0)
(0)
Pre-Tax Income
(0)
N/A
(0)
-56%
(0)
-186%
(0)
-3%
(2)
-359%
(2)
+2%
(2)
+10%
(2)
+2%
(2)
-37%
(4)
-60%
(5)
-53%
(7)
-32%
(8)
-11%
(8)
-6%
(5)
+45%
(2)
+56%
(2)
+18%
3
N/A
3
+3%
4
+4%
3
-22%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
Income from Continuing Operations
(0)
(0)
(0)
(0)
(2)
(2)
(2)
(2)
(2)
(4)
(5)
(7)
(8)
(8)
(5)
(2)
(2)
3
3
4
3
Net Income (Common)
(0)
N/A
(0)
-56%
(0)
-186%
(0)
N/A
(2)
-358%
(2)
+1%
(2)
+10%
(2)
+2%
(2)
-40%
(4)
-60%
(5)
-53%
(7)
-32%
(8)
-11%
(8)
-6%
(5)
+45%
(2)
+56%
(2)
+18%
3
N/A
3
+4%
4
+4%
3
-22%
EPS (Diluted)
-0.57
N/A
-1.75
-207%
-0.55
+69%
-0.81
-47%
-3.81
-370%
-2.82
+26%
-2.43
+14%
-2.38
+2%
-0.03
+99%
-0.05
-67%
-0.08
-60%
-0.1
-25%
-0.11
-10%
-0.11
N/A
-0.06
+45%
-0.02
+67%
-0.01
+50%
0.03
N/A
0.04
+33%
0.03
-25%
0.02
-33%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett